Occasional spontaneous clearance of chronic hepatitis C virus in HIV-infected individuals

Journal of Hepatology

Volumn 61, Issue 4, 2014, Pages 957-961

  Stenkvist, Jenny ^a,b   Nyström, Jessica ^a   Falconer, Karolin ^a,b   Sönnerborg, Anders ^a   Weiland, Ola ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HCV; HIV; HIV HCV co infection; IL28B

Indexed keywords

ABACAVIR; ALANINE AMINOTRANSFERASE; ATAZANAVIR PLUS RITONAVIR; BILIRUBIN; EMTRICITABINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; RALTEGRAVIR; STAVUDINE; TENOFOVIR; ANTIRETROVIRUS AGENT; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DRUG WITHDRAWAL; ELASTOGRAPH; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRANSAMINASEMIA; IL28B GENE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MIXED INFECTION; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; BLOOD; GENETIC ASSOCIATION; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; IMMUNOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REMISSION; RETROSPECTIVE STUDY; SEROLOGY; SWEDEN; VIROLOGY; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; GENETIC ASSOCIATION STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; RNA, VIRAL; SEROLOGIC TESTS; SWEDEN; VIRAL LOAD;

EID: 84926392011     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.06.014     Document Type: Article

References (19)

1. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
2. Jimenez-Sousa MA, Fernandez-Rodriguez A, Guzman-Fulgencio M, Garcia- Alvarez M, Resino S. Meta-analysis: implications of interleukin-28B poly- morphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Med 2013; 11: 6.
3. Rallon NI, Naggie S, Benito JM, Medrano J, Restrepo C, Goldstein D, et al. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. AIDS 2010; 24: F23-F29.
4. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138: 1338-1345, 1345 e1331-e1337.
5. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.
6. De Rosa FG, Audagnotto S, Bargiacchi O, Garazzino S, Marucco D Aguilar, Veronese L, et al. Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient. J Infect 2006; 53: e215-e218.
7. Endo T, Fujimoto K, Nishio M, Yamamoto S, Obara M, Sato N, et al. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus. J Med Virol 2009; 81: 979-982.
8. Falconer K, Gonzalez VD, Reichard O, Sandberg JK, Alaeus A. Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. J Clin Virol 2008; 41: 160-163.
9. Fialaire P, Payan C, Vitour D, Chennebault JM, Loison J, Pichard E, et al. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection. J Infect Dis 1999; 180: 574-575.
10. Manfredi R, Dentale N, Calza L. Spontaneous clearance of chronic hepatitis C infection in a patient with a 20-year-old HIV-hepatitis C co-infection and chronic active hepatitis. Int J STD AIDS 2012; 23: e48-e50.
11. Perez-Olmeda M, Garcia-Samaniego J, Soriano V. Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy. AIDS 2000; 14: 212.
12. Ranieri R, Santambrogio C, Veronelli A, Pontiroli AE. Hepatitis C viremia persistently suppressed by HAART. Clin Infect Dis 2003; 36: 1086-1087.
13. Torti C, Barnes E, Quiros-Roldan E, Puoti M, Carosi G, Klenerman P. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection. Antivir Ther 2004; 9: 139-142.
14. Weissbrich B, Langmann P, Schubert J, Jassoy C, Klinker H. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flareups. Eur J Med Res 2003; 8: 495-498.
15. Zeitoun JD, Mallet V, Chaix ML, Viard JP, Blanche S, Pol S. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy. J Clin Virol 2007; 40: 71-73.
16. Vispo E, Barreiro P, Plaza Z, Fernandez-Montero JV, Labarga P, de Mendoza C, et al. Spontaneous HCV clearance in HIV patients with chronic hepatitis Cbearing IL28B-CC alleles using antiretroviral therapy. AIDS 2014; 28: 1473-1478.
17. Stenkvist J, Weiland O, Sönnerborg A, Blaxhult A, Falconer K. High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort. Scand J Infect Dis 2014: 1-9.
18. Bahra M, Jacob D, Neumann UP, Spies F, Langrehr JM, Berg T, et al. Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C. Transplantation 2007; 84: 144-148.
19. Casanovas-Taltavull T, Ercilla MG, Gonzalez CP, Gil E, Vinas O, Canas C, et al. Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance. Liver Transpl 2004; 10: 584-594.